Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:342-348
Published online before print July 21, 2003, doi: 10.1161/01.HYP.0000084602.06114.AD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/3/342    most recent
01.HYP.0000084602.06114.ADv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, T.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, T.
Right arrow Articles by Ogihara, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats

(Hypertension. 2003;42:342.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Eicosapentaenoic Acid Protects Endothelial Cells Against Anoikis Through Restoration of cFLIP

Takashi Suzuki; Keisuke Fukuo; Toshimitsu Suhara; Osamu Yasuda; Naoyuki Sato; Yukihiro Takemura; Maki Tsubakimoto; Toshio Ogihara

From the Department of Geriatric Medicine, Osaka University Medical School, Osaka, Japan.

Correspondence to Keisuke Fukuo, MD, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka, Japan. E-mail fukuo{at}geriat.med.osaka-u.ac.jp

Dietary supplementation with eicosapentaenoic acid (EPA) improves the prognosis of chronic inflammatory diseases, including atherosclerosis. The mechanism underlying these beneficial effects, however, remains to be elucidated. Here we show that EPA protects endothelial cells from anoikis through upregulation of the cellular FLICE (Fas-associating protein with death domain-like interleukin-1–converting enzyme)-inhibitory protein (cFLIP), an endogenous inhibitor of caspase-8. EPA-induced upregulation of cFLIP expression was partially suppressed by the phosphatidylinositol-3-kinase inhibitor wortmannin. Conversely, treatment with insulinlike growth factor-1 (IGF-1), an activator of phosphatidylinositol-3-kinase/Akt signaling, or infection with an adenoviral construct expressing the constitutively active Akt gene induced upregulation of cFLIP expression. In addition, pretreatment of endothelial cells with either EPA or IGF-1 protected them from anoikis, suggesting that EPA-induced protection against anoikis is partially mediated through activation of Akt. On the other hand, when endothelial cells were already detached, treatment of these cells with EPA but not with IGF-1 protected them against anoikis. Importantly, EPA restored cFLIP expression without activating Akt signaling in detached endothelial cells, whereas IGF-1 had no effect. Additionally, exogenously restored expression of cFLIP by the tetracycline-regulated adenovirus system protected endothelial cells against anoikis. Furthermore, EPA was protective against the loss of endothelium in an organ culture of rat aortas. These findings suggest that EPA protects against endothelial cell anoikis through restoration of cFLIP expression, which might contribute to the mechanism underlying the beneficial effects of EPA in patients with hypertension.


Key Words: fish oils • endothelium • apoptosis • anoikis • tumor necrosis factor • protein kinase




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. Artwohl, A. Lindenmair, V. Sexl, C. Maier, G. Rainer, A. Freudenthaler, N. Huttary, M. Wolzt, P. Nowotny, A. Luger, et al.
Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells
J. Lipid Res., December 1, 2008; 49(12): 2627 - 2640.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. H. Endemann and E. L. Schiffrin
Endothelial Dysfunction
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. L. Schiffrin and R. M. Touyz
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446.
[Full Text] [PDF]


Home page
HypertensionHome page
T. Suhara, K. Fukuo, O. Yasuda, M. Tsubakimoto, Y. Takemura, H. Kawamoto, T. Yokoi, M. Mogi, T. Kaimoto, and T. Ogihara
Homocysteine Enhances Endothelial Apoptosis via Upregulation of Fas-Mediated Pathways
Hypertension, June 1, 2004; 43(6): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Takemura, K. Fukuo, O. Yasuda, T. Inoue, N. Inomata, T. Yokoi, H. Kawamoto, T. Suhara, and T. Ogihara
Fas Signaling Induces Akt Activation and Upregulation of Endothelial Nitric Oxide Synthase Expression
Hypertension, April 1, 2004; 43(4): 880 - 884.
[Abstract] [Full Text] [PDF]